| Table 2: Summary of reactivity of CENPF patient sera with CENPF (pF) epitopes | |||||
| Epitope; no. (and %) of patients | |||||
| Patient group | pF1 | pF2 | pF3 | pF4 | pF5 |
| Total patients | 16/30 (53) | 24/33 (73) | 23/33 (70) | 26/33 (79) | 24/31 (77) |
| Patients with neoplasm | 9/19 (47) | 18/21 (86) | 17/21 (81) | 21/21 (100) | 19/20 (95) |
| Patients without neoplasm | 7/11 (63) | 6/12 (50) | 6/12 (50) | 5/12 (42) | 5/11 (45) |
| Statistic | |||||
| p value* | 0.4664 | 0.0441 | 0.1142 | 0.0002 | 0.0036 |
| Odds ratio | 0.5143 | 6.000 | 4.250 | 58.636 | 22.800 |
| 95% confidence interval† | 0.1121-2.360 | 1.134-31.748 | 0.8833-20.449 | 2.882-1192.9 | 2.206-235.65 |
| *Fisher's exact test.
†Using the approximation of Woolf. |
|||||
[ Return to text ]